KPV for Skin: What the Evidence Shows
What human and animal studies show about KPV for skin, how strong that evidence is, and what is still unproven.
- Strongest evidence
- In vitro
- Human studies
- 1
- PubMed records, our ledger
- Animal studies
- 1
- PubMed records, our ledger
- Studies we summarised
- 3
- with an outcome for skin
Evidence for skin
Each row is an outcome related to skin from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Keratinocyte viability and IL-1beta | KPV at 50 ug/mL restored cell viability and reduced IL-1beta secretion in PM10-exposed keratinocytes. | In vitro (not a human result) | Tissue & cell 2025, PMID 40073467 |
| Skin permeation | KPV did not permeate human skin by passive diffusion alone (below the detection limit of 0.01 ug/mL); microneedles and iontophoresis were needed. | In vitro (not a human result) | Journal of pharmaceutical sciences 2017, PMID 28343991 |
| Cyclic AMP signalling | KPV did not raise cyclic AMP in human keratinocytes (mechanism study; no clinical outcome). | In vitro (not a human result) | The Journal of investigative dermatology 2004, PMID 15102092 |
PubMed records for KPV and skin: 1 human, 1 animal (search counts, not studies we reviewed). Grades follow our .
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
Skin conditions people search KPV for
MedlinePlus says eczema is a term for several different types of skin swelling, also called dermatitis.[4]
MedlinePlus describes rosacea as a long-term disease that affects the skin and sometimes the eyes, causing redness and pimples.[5]
Skin-cell and tissue work on KPV
In a three-dimensional skin model, KPV treatment attenuated the inflammatory cell death induced by PM10.[1]
A second keratinocyte study found KPV raised intracellular calcium in HaCaT cells, but only in the presence of PIA, an adenosine agonist that inhibits the cyclic AMP pathway.[3]
A donor-skin delivery study found KPV permeation by simple passive diffusion was below detectable levels.[2]
In the same study, microneedle treatment raised KPV permeation to 4.4 μg/cm2/h.[2]
A stability study found KPV broke down under acid, alkali and peroxide stress into lys-pro-diketopiperazine.[6]
What is missing
The skin-quality PubMed query for KPV (run 2026-10-02) found 3 human-tagged records (1 human-only), 1 animal record and 0 randomized trials among 4 in all.
Calculated from human 3; human only 1; animal 1; rct 0; all 4. Formula: Counts copied from the kpv ledger row of the skin goal in goals.json; no arithmetic.
Across 9 KPV papers there are 0 participant studies; the skin evidence is cultured keratinocytes, a lab skin model and donor skin.
Calculated from kpv studies in evidence file 9; human participant studies 0. Formula: Study designs counted from web/src/data/evidence/kpv.json (animal, in-vitro); no arithmetic.
Other peptides people research for skin
All peptides for skin, comparedCommon questions
Does KPV help with skin?
The strongest study we summarise for skin is in vitro evidence, across 3 studies with an outcome for skin. That is not proof it works in people.
Is KPV approved for skin?
No. KPV is not FDA approved for any use, including skin.
What is the best peptide for skin?
There is no single answer. Our skin overview compares each candidate by evidence grade and legal status rather than by popularity.
Does KPV help eczema?
No eczema study of KPV is in our files; the skin work is keratinocyte culture, a 3D skin model and donor-skin delivery tests.[1]
Is KPV good for rosacea?
No rosacea data exist for it; MedlinePlus defines rosacea as long-term facial redness and pimples, which none of the cached KPV papers measured.[5]
Can KPV be absorbed through the skin?
In donor skin, simple passive diffusion gave no detectable KPV (limit of detection 0.01 μg/mL).[2]
More on KPV
Sources
- 1Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.Tissue & cell · 2025PMID 40073467Accessed 2 Oct 2026
- 2Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.Journal of pharmaceutical sciences · 2017PMID 28343991Accessed 2 Oct 2026
- 3alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells.The Journal of investigative dermatology · 2004PMID 15102092Accessed 2 Oct 2026
- 4Official web pageOfficial web page · web page
- 5Official web pageOfficial web page · web page
- 6Stability-indicating HPLC assay for lysine-proline-valine (KPV) in aqueous solutions and skin homogenates.Biomedical chromatography : BMC · 2015PMID 25298219Accessed 2 Oct 2026
Found an error? Report a correction.